{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:54:13Z","timestamp":1789624453469,"version":"build-2803163510"},"reference-count":42,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11,1]]},"DOI":"10.1210\/jc.2007-2356","type":"journal-article","created":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T02:59:05Z","timestamp":1219201145000},"page":"4462-4470","source":"Crossref","is-referenced-by-count":29,"title":["Fatty Acid Metabolism in Patients with PPAR\u03b3 Mutations"],"prefix":"10.1210","volume":"93","author":[{"given":"Garry D.","family":"Tan","sequence":"first","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology, and Metabolism (G.D.T., B.A.F., J.C., L.H., S.M.H., K.N.F., F.K.), University of Oxford, Churchill Hospital, Oxford OX3 7LJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Savage","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Clinical Biochemistry (D.B.S., S.O., K.C.), Addenbrooke\u2019s Hospital, Cambridge CB2 2QQ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Fielding","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology, and Metabolism (G.D.T., B.A.F., J.C., L.H., S.M.H., K.N.F., F.K.), University of Oxford, Churchill Hospital, Oxford OX3 7LJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Collins","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology, and Metabolism (G.D.T., B.A.F., J.C., L.H., S.M.H., K.N.F., F.K.), University of Oxford, Churchill Hospital, Oxford OX3 7LJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Hodson","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology, and Metabolism (G.D.T., B.A.F., J.C., L.H., S.M.H., K.N.F., F.K.), University of Oxford, Churchill Hospital, Oxford OX3 7LJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy M.","family":"Humphreys","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology, and Metabolism (G.D.T., B.A.F., J.C., L.H., S.M.H., K.N.F., F.K.), University of Oxford, Churchill Hospital, Oxford OX3 7LJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"O'Rahilly","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Clinical Biochemistry (D.B.S., S.O., K.C.), Addenbrooke\u2019s Hospital, Cambridge CB2 2QQ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Clinical Biochemistry (D.B.S., S.O., K.C.), Addenbrooke\u2019s Hospital, Cambridge CB2 2QQ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith N.","family":"Frayn","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology, and Metabolism (G.D.T., B.A.F., J.C., L.H., S.M.H., K.N.F., F.K.), University of Oxford, Churchill Hospital, Oxford OX3 7LJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Karpe","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology, and Metabolism (G.D.T., B.A.F., J.C., L.H., S.M.H., K.N.F., F.K.), University of Oxford, Churchill Hospital, Oxford OX3 7LJ, United Kingdom"},{"name":"National Institute for Health and Research (NIHR) Oxford Biomedical Research Centre (F.K.), University of Oxford, Churchill Hospital, Oxford OX3 7LJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114015383700_R1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/3099","article-title":"A Pro12Ala substitution in PPAR\u03b32 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.","volume":"20","author":"Deeb","year":"1998","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041114015383700_R2","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s001250100629","article-title":"Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-\u03b32 (PPAR-\u03b32) gene in relation to insulin sensitivity among glucose tolerant Caucasians.","volume":"44","author":"Ek","year":"2001","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041114015383700_R3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s001250051225","article-title":"The PPAR\u03b32 amino acid polymorphism Pro 12 Ala is prevalent in offspring of type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects.","volume":"42","author":"Koch","year":"1999","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041114015383700_R4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/bbrc.2000.2605","article-title":"The Pro12Ala polymorphism in PPAR\u03b32 may confer resistance to type 2 diabetes.","volume":"271","author":"Hara","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t2019041114015383700_R5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.ejhg.5201283","article-title":"The common PPAR-\u03b32 Pro12Ala variant is associated with greater insulin sensitivity.","volume":"12","author":"Buzzetti","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"key\n\t\t\t\t2019041114015383700_R6","first-page":"408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-\u03b3 gene in a patient with familial partial lipodystrophy.","volume":"87","author":"Agarwal","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114015383700_R7","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114015383700_R8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPAR\u03b3 associated with severe insulin resistance, diabetes mellitus and hypertension.","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041114015383700_R9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00125-004-1619-9","article-title":"The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.","volume":"48","author":"Tan","year":"2005","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041114015383700_R10","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s001250100031","article-title":"Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients.","volume":"44","author":"Miyazaki","year":"2001","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041114015383700_R11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2337\/diabetes.49.5.827","article-title":"Mechanism of troglitazone action in type 2 diabetes.","volume":"49","author":"Petersen","year":"2000","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114015383700_R12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s125-002-8257-y","article-title":"Reduced lipolysis as possible cause for greater weight gain in subjects with the Pro12Ala polymorphism in PPAR\u03b32?","volume":"45","author":"Stumvoll","year":"2002","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041114015383700_R13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2007-978663","article-title":"The PPAR\u03b32 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients.","volume":"32","author":"Jacob","year":"2000","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041114015383700_R14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/ann.34.3.217.224","article-title":"Glitazones: clinical effects and molecular mechanisms.","volume":"34","author":"Stumvoll","year":"2002","journal-title":"Ann Med"},{"key":"key\n\t\t\t\t2019041114015383700_R15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00125-005-0044-z","article-title":"The in vivo effects of the Pro12Ala PPAR\u03b32 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.","volume":"49","author":"Tan","year":"2006","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041114015383700_R16","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2006-1807","article-title":"Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-\u03b3.","volume":"92","author":"Monajemi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114015383700_R17","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.2005-2624","article-title":"Peroxisome proliferator-activated receptor-\u03b3 C190S mutation causes partial lipodystrophy.","volume":"92","author":"Ludtke","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114015383700_R18","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1136\/jmg.2007.050567","article-title":"New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand","volume":"44","author":"Ludtke","year":"2007","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t2019041114015383700_R19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2006.09.003","article-title":"Non-DNA binding, dominant-negative, human PPAR\u03b3 mutations cause lipodystrophic insulin resistance.","volume":"4","author":"Agostini","year":"2006","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t2019041114015383700_R20","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diabetes.52.4.910","article-title":"Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-\u03b3.","volume":"52","author":"Savage","year":"2003","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114015383700_R21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng926","article-title":"Digenic inheritance of severe insulin resistance in a human pedigree.","volume":"31","author":"Savage","year":"2002","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041114015383700_R22","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies.","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114015383700_R23","first-page":"269","article-title":"Assessment of white adipose tissue metabolism by measurement of arteriovenous differences.","volume":"155","author":"Frayn","year":"2001","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t2019041114015383700_R24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/cs0760509","article-title":"Metabolic characteristics of human adipose tissue in vivo.","volume":"76","author":"Frayn","year":"1989","journal-title":"Clin Sci (Lond)"},{"key":"key\n\t\t\t\t2019041114015383700_R25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1748-1716.1966.tb03208.x","article-title":"Blood flow through human adipose tissue determined with radioactive xenon.","volume":"66","author":"Larsen","year":"1966","journal-title":"Acta Physiol Scand"},{"key":"key\n\t\t\t\t2019041114015383700_R26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1017\/S0029665199001196","article-title":"Limb and skeletal muscle blood flow measurements at rest and during exercise in human subjects.","volume":"58","author":"Ra\u030adegran","year":"1999","journal-title":"Proc Nutr Soc"},{"key":"key\n\t\t\t\t2019041114015383700_R27","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.2337\/diabetes.51.9.2684","article-title":"Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle.","volume":"51","author":"Evans","year":"2002","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114015383700_R28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipids from animal tissues.","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114015383700_R29","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1017\/S0007114500002154","article-title":"A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction.","volume":"84","author":"Burdge","year":"2000","journal-title":"Br J Nutr"},{"key":"key\n\t\t\t\t2019041114015383700_R30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ajcn\/63.1.36","article-title":"Postprandial lipemia: the origin of an early peak studied by specific dietary fatty acid intake during sequential meals.","volume":"63","author":"Fielding","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t2019041114015383700_R31","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","article-title":"Correct homeostasis model assessment (HOMA) evaluation uses the computer program.","volume":"21","author":"Levy","year":"1998","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041114015383700_R32","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1074\/jbc.M512943200","article-title":"Rosiglitazone controls fatty acid cycling in human adipose tissue by means of glyceroneogenesis and glycerol phosphorylation.","volume":"281","author":"Leroyer","year":"2006","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114015383700_R33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nm0703-811","article-title":"A \u201cfutile cycle\u201d induced by thiazolidinediones in human adipose tissue?","volume":"9","author":"Tan","year":"2003","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2019041114015383700_R34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1172\/JCI8538","article-title":"Improved insulin-sensitivity in mice heterozygous for PPAR-\u03b3 deficiency.","volume":"105","author":"Miles","year":"2000","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114015383700_R35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5551\/jat1994.3.81","article-title":"Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.","volume":"3","author":"Auwerx","year":"1996","journal-title":"J Atheroscler Thromb"},{"key":"key\n\t\t\t\t2019041114015383700_R36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1464-5491.2003.01034.x","article-title":"Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene.","volume":"20","author":"Owen","year":"2003","journal-title":"Diabet Med"},{"key":"key\n\t\t\t\t2019041114015383700_R37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2337\/diacare.22.2.288","article-title":"Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes.","volume":"22","author":"Kelly","year":"1999","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041114015383700_R38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/07853899709002451","article-title":"Differences in lipolysis between human subcutaneous and omental adipose tissues.","volume":"27","author":"Arner","year":"1995","journal-title":"Ann Med"},{"key":"key\n\t\t\t\t2019041114015383700_R39","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI21047","article-title":"Splanchnic lipolysis in human obesity.","volume":"113","author":"Nielsen","year":"2004","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114015383700_R40","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.2337\/diabetes.48.8.1586","article-title":"Regional postprandial fatty acid metabolism in different obesity phenotypes.","volume":"48","author":"Guo","year":"1999","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114015383700_R41","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ajcn\/81.6.1405","article-title":"Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome.","volume":"81","author":"Sekhar","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t2019041114015383700_R42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11883-004-0029-2","article-title":"Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy.","volume":"6","author":"Sekhar","year":"2004","journal-title":"Curr Atheroscler Rep"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/11\/4462\/9055688\/jcem4462.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T05:24:02Z","timestamp":1631683442000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/11\/4462\/2627307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,1]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-2356","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,1]]}}}